BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

494 related articles for article (PubMed ID: 23209411)

  • 21. Interferon regulatory factor 5-dependent immune responses in the draining lymph node protect against West Nile virus infection.
    Thackray LB; Shrestha B; Richner JM; Miner JJ; Pinto AK; Lazear HM; Gale M; Diamond MS
    J Virol; 2014 Oct; 88(19):11007-21. PubMed ID: 25031348
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic diversity in the collaborative cross model recapitulates human West Nile virus disease outcomes.
    Graham JB; Thomas S; Swarts J; McMillan AA; Ferris MT; Suthar MS; Treuting PM; Ireton R; Gale M; Lund JM
    mBio; 2015 May; 6(3):e00493-15. PubMed ID: 25944860
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chemokine Receptor Ccr7 Restricts Fatal West Nile Virus Encephalitis.
    Bardina SV; Brown JA; Michlmayr D; Hoffman KW; Sum J; Pletnev AG; Lira SA; Lim JK
    J Virol; 2017 May; 91(10):. PubMed ID: 28356527
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Interferon-Stimulated Gene Ifitm3 Restricts West Nile Virus Infection and Pathogenesis.
    Gorman MJ; Poddar S; Farzan M; Diamond MS
    J Virol; 2016 Sep; 90(18):8212-25. PubMed ID: 27384652
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CCR5 limits cortical viral loads during West Nile virus infection of the central nervous system.
    Durrant DM; Daniels BP; Pasieka T; Dorsey D; Klein RS
    J Neuroinflammation; 2015 Dec; 12():233. PubMed ID: 26667390
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Interferon-Stimulated Gene Ifi27l2a Restricts West Nile Virus Infection and Pathogenesis in a Cell-Type- and Region-Specific Manner.
    Lucas TM; Richner JM; Diamond MS
    J Virol; 2015 Dec; 90(5):2600-15. PubMed ID: 26699642
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Peli1 facilitates virus replication and promotes neuroinflammation during West Nile virus infection.
    Luo H; Winkelmann ER; Zhu S; Ru W; Mays E; Silvas JA; Vollmer LL; Gao J; Peng BH; Bopp NE; Cromer C; Shan C; Xie G; Li G; Tesh R; Popov VL; Shi PY; Sun SC; Wu P; Klein RS; Tang SJ; Zhang W; Aguilar PV; Wang T
    J Clin Invest; 2018 Nov; 128(11):4980-4991. PubMed ID: 30247157
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Death receptor-mediated apoptotic signaling is activated in the brain following infection with West Nile virus in the absence of a peripheral immune response.
    Clarke P; Leser JS; Quick ED; Dionne KR; Beckham JD; Tyler KL
    J Virol; 2014 Jan; 88(2):1080-9. PubMed ID: 24198425
    [TBL] [Abstract][Full Text] [Related]  

  • 29. West Nile virus: immunity and pathogenesis.
    Lim SM; Koraka P; Osterhaus AD; Martina BE
    Viruses; 2011 Jun; 3(6):811-28. PubMed ID: 21994755
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PKR and RNase L contribute to protection against lethal West Nile Virus infection by controlling early viral spread in the periphery and replication in neurons.
    Samuel MA; Whitby K; Keller BC; Marri A; Barchet W; Williams BR; Silverman RH; Gale M; Diamond MS
    J Virol; 2006 Jul; 80(14):7009-19. PubMed ID: 16809306
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Minocycline Has Anti-inflammatory Effects and Reduces Cytotoxicity in an
    Quick ED; Seitz S; Clarke P; Tyler KL
    J Virol; 2017 Nov; 91(22):. PubMed ID: 28878079
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The critical role of interleukin-6 in protection against neurotropic flavivirus infection.
    Auroni TT; Arora K; Natekar JP; Pathak H; Elsharkawy A; Kumar M
    Front Cell Infect Microbiol; 2023; 13():1275823. PubMed ID: 38053527
    [TBL] [Abstract][Full Text] [Related]  

  • 33. IL-1R1 is required for dendritic cell-mediated T cell reactivation within the CNS during West Nile virus encephalitis.
    Durrant DM; Robinette ML; Klein RS
    J Exp Med; 2013 Mar; 210(3):503-16. PubMed ID: 23460727
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CD4+ T-cell responses are required for clearance of West Nile virus from the central nervous system.
    Sitati EM; Diamond MS
    J Virol; 2006 Dec; 80(24):12060-9. PubMed ID: 17035323
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CD8+ T cells require perforin to clear West Nile virus from infected neurons.
    Shrestha B; Samuel MA; Diamond MS
    J Virol; 2006 Jan; 80(1):119-29. PubMed ID: 16352536
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pro-inflammatory cytokines derived from West Nile virus (WNV)-infected SK-N-SH cells mediate neuroinflammatory markers and neuronal death.
    Kumar M; Verma S; Nerurkar VR
    J Neuroinflammation; 2010 Oct; 7():73. PubMed ID: 21034511
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Persistence of virus-specific immune responses in the central nervous system of mice after West Nile virus infection.
    Stewart BS; Demarest VL; Wong SJ; Green S; Bernard KA
    BMC Immunol; 2011 Jan; 12():6. PubMed ID: 21251256
    [TBL] [Abstract][Full Text] [Related]  

  • 38. STAT5: a Target of Antagonism by Neurotropic Flaviviruses.
    Zimmerman MG; Bowen JR; McDonald CE; Young E; Baric RS; Pulendran B; Suthar MS
    J Virol; 2019 Dec; 93(23):. PubMed ID: 31534033
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumor necrosis factor alpha protects against lethal West Nile virus infection by promoting trafficking of mononuclear leukocytes into the central nervous system.
    Shrestha B; Zhang B; Purtha WE; Klein RS; Diamond MS
    J Virol; 2008 Sep; 82(18):8956-64. PubMed ID: 18632856
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alpha/beta interferon protects against lethal West Nile virus infection by restricting cellular tropism and enhancing neuronal survival.
    Samuel MA; Diamond MS
    J Virol; 2005 Nov; 79(21):13350-61. PubMed ID: 16227257
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.